Renova Therapeutics leadership speaking at Cell & Gene Therapy CEO forum and Boulder Peptide Symposium

Monday, September 25, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

Peter Gengo, Ph.D., Vice President of Preclinical Research and Pharmacology at Renova Therapeutics

Renova Therapeutics is a San Diego-based biopharmaceutical company developing gene therapy treatments for congestive heart failure and other chronic diseases. (PRNewsFoto/Renova Therapeutics)



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook